BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 29524128)

  • 1. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
    Waryah CB; Moses C; Arooj M; Blancafort P
    Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of TALE-Based Designer Epigenome Modifiers.
    Nitsch S; Mussolino C
    Methods Mol Biol; 2018; 1767():89-109. PubMed ID: 29524130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.
    Sen D; Keung AJ
    Methods Mol Biol; 2018; 1767():65-87. PubMed ID: 29524129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. dCas9: A Versatile Tool for Epigenome Editing.
    Brocken DJW; Tark-Dame M; Dame RT
    Curr Issues Mol Biol; 2018; 26():15-32. PubMed ID: 28879853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editing the Epigenome: Overview, Open Questions, and Directions of Future Development.
    Rots MG; Jeltsch A
    Methods Mol Biol; 2018; 1767():3-18. PubMed ID: 29524127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications.
    Xu X; Hulshoff MS; Tan X; Zeisberg M; Zeisberg EM
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Toolboxes for Precision Genome/Epigenome Editing and Imaging of Epigenetics.
    Nomura W
    Chem Rec; 2018 Dec; 18(12):1717-1726. PubMed ID: 30066981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenome Editing in the Brain.
    Bashtrykov P; Jeltsch A
    Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Native Cas9: Manipulating Genomic Information and Function.
    Mitsunobu H; Teramoto J; Nishida K; Kondo A
    Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editing the epigenome: technologies for programmable transcription and epigenetic modulation.
    Thakore PI; Black JB; Hilton IB; Gersbach CA
    Nat Methods; 2016 Feb; 13(2):127-37. PubMed ID: 26820547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors.
    Fang Y; Stroukov W; Cathomen T; Mussolino C
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted genome regulation via synthetic programmable transcriptional regulators.
    Piatek A; Mahfouz MM
    Crit Rev Biotechnol; 2017 Jun; 37(4):429-440. PubMed ID: 27093352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
    Xu X; Qi LS
    J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
    Cuculis L; Schroeder CM
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances of epigenetic editing.
    Gjaltema RAF; Rots MG
    Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-based reagents to study the influence of the epigenome on gene expression.
    Lavender P; Kelly A; Hendy E; McErlean P
    Clin Exp Immunol; 2018 Oct; 194(1):9-16. PubMed ID: 30030848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene editing for cell engineering: trends and applications.
    Gupta SK; Shukla P
    Crit Rev Biotechnol; 2017 Aug; 37(5):672-684. PubMed ID: 27535623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.